Targeting the Alpha 7 Nicotinic Acetylcholine Receptor to Reduce Amyloid Accumulation in Alzheimer's Disease Pyramidal Neurons

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|6|677-684

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.6, 2006-02, pp. : 677-684

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

α7 Nicotinic Acetylcholine Receptors in Alzheimer’s Disease: Neuroprotective, Neurotrophic or Both?

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 613-622

Bentham Science Publishers

Access to resources Recommend Favorite

α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson’s Disease

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 623-630

Bentham Science Publishers

Access to resources Recommend Favorite

α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease

By Geerts Hugo  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 59-65

Informa Healthcare

Access to resources Recommend Favorite

The Role of 7 Nicotinic Acetylcholine Receptors and 7-Specific Antibodies in Neuroinflammation Related to Alzheimer Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2035-2049

Bentham Science Publishers

Access to resources Recommend Favorite

Selective 7 Nicotinic Acetylcholine Receptor Ligands

By  

Current Medicinal Chemistry, Vol. 13, Iss. 13, 2006-06 ,pp. : 1567-1584

Bentham Science Publishers

Access to resources Recommend Favorite